Independent educationNo sales. No dosing. Sources on every brief.

Exact claim · Version 1 · Reviewed 2026-07-23

“TB-500 is the same thing as thymosin beta-4.”

A verdict on this wording and scope, not a universal grade for TB-500.

01 · Verdict

Misleading

FDA describes TB-500 as a seven-amino-acid fragment of the much larger thymosin beta-4 molecule.

Evidence basis
Regulatory or product record
Scope
Chemical identity, not a claim about all possible biological activity.
Category
Mechanism and biomarkers

02 · Primary record

Check the attached evidence

Editorial review
Internal editorial review recorded
Responsible editor
Anthony Treviso · Founder and responsible editor
Clinical-review boundary
Not independently medically reviewed.